沭舒坦氧气雾化吸入治疗慢性阻塞性肺疾病急性加重期的疗效观察及护理  

Effect and Nursing Methods of Oxygen Inhalation of Mucosolvan for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

作　　者：劳雁[1] 劳龙燕 李冬梅[1] 黄春媛[1] 吴秀萍[1] 

机构地区：[1]湛江中心人民医院,广东湛江524037

出　　处：《中国伤残医学》2015年第11期35-37,共3页Chinese Journal of Trauma and Disability Medicine

摘　　要：目的：探讨沐舒坦氧气雾化吸入治疗慢性阻塞性肺疾病急性加重期（AECOPD）的疗效及护理方法。方法：选择96例AECOPD患者随机均分为2组。在常规综合性治疗基础上，对照组给予生理盐水5ml氧气雾化吸入，2次／d，观察组给予生理盐水4ml和沐舒坦15mg氧气雾化吸入，2次／d。2组患者均给予氧气雾化吸入护理，治疗7天评价疗效。结果：观察组显效33例、有效11例、无效4例，对照组显效20例、有效16例、无效12例，2组患者的疗效比较，差异有统计学意义（P〈0．01）。结论：沐舒坦氧气雾化吸入治疗配合有效的护理可明显提高AECOPD患者的疗效，值得临床推广应用。Objective：To explore the effect and nursing methods of oxygen inhalation of mucosolvan for patients with AECOPD. Methods： Totally 96 patients with AECOPD were randomly divided into two groups. All the patients received routine treatment. In addition, the control group received oxygen inhalation of normal saline, and the observation group received oxygen inhalation of mucosolvan . The therapeutic effects were evaluated after treatment and nursing for 7 days. Results： Therapeutic effect in the observation group were signifi- cantly better than the control group, the difference was statistically significant（ P 〈 0. 01 ）. Conclusion： Oxygen inhalation of mucosolvan can improve the therapeutic effects of AECOPD effectively, it is worthy for clinical application.

关 键 词：慢性阻塞性肺疾病 沐舒坦 氧气雾化吸入 疗效 护理 

分 类 号：R563[医药卫生—呼吸系统]